Marco Biondini

478 total citations
11 papers, 323 citations indexed

About

Marco Biondini is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Marco Biondini has authored 11 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cell Biology, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Marco Biondini's work include Cellular Mechanics and Interactions (5 papers), Cell Adhesion Molecules Research (2 papers) and Microtubule and mitosis dynamics (2 papers). Marco Biondini is often cited by papers focused on Cellular Mechanics and Interactions (5 papers), Cell Adhesion Molecules Research (2 papers) and Microtubule and mitosis dynamics (2 papers). Marco Biondini collaborates with scholars based in Canada, France and United States. Marco Biondini's co-authors include Maria Carla Parrini, Jacques Camonis, Peter M. Siegel, April A. N. Rose, Rafael E. Curiel, Pascal Silberzan, Giulia Zago, Axel Buguin, Maxime Déforet and Laurence Petitjean and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cell and Nature Methods.

In The Last Decade

Marco Biondini

10 papers receiving 321 citations

Peers

Marco Biondini

MB

CB

ONCOL

BE

IA

Mike Edward United Kingdom

Elisa Barbieri Italy

Yuliya Petrova United States

Wies van Roosmalen Netherlands

Hailey E. Brighton United States

Laurence Veracini France

Jenna A. Mosier United States

Claudia Asperti Italy

Jenny Tadros United States

Nicolas Molinié France

Mike Edward United Kingdom

Marco Biondini

192 ×1.2

MB

102 ×0.8

CB

109 ×1.3

ONCOL

69 ×1.7

BE

30 ×0.9

IA

Citations per year, relative to Marco Biondini Marco Biondini (= 1×) peers Mike Edward

Countries citing papers authored by Marco Biondini

Since Specialization

Citations

This map shows the geographic impact of Marco Biondini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Biondini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Biondini more than expected).

Fields of papers citing papers by Marco Biondini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Biondini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Biondini. The network helps show where Marco Biondini may publish in the future.

Co-authorship network of co-authors of Marco Biondini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Biondini. A scholar is included among the top collaborators of Marco Biondini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Biondini. Marco Biondini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Elkholi, Islam E., Shannon A. Fraser, Marco Biondini, et al.. (2025). Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.. Journal of Clinical Oncology. 43(16_suppl). 3117–3117.

2.

Minarrieta, Lucía, Matthew G. Annis, Yannick Audet-Delage, et al.. (2024). Mitochondrial elongation impairs breast cancer metastasis. Science Advances. 10(45). eadm8212–eadm8212. 15 indexed citations

3.

Paquette, Mathieu, Ming Yan, Leeanna El–Houjeiri, et al.. (2021). Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways. Scientific Reports. 11(1). 21268–21268. 9 indexed citations

4.

Rose, April A. N., Marco Biondini, Rafael E. Curiel, & Peter M. Siegel. (2017). Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer. Pharmacology & Therapeutics. 179. 127–141. 67 indexed citations

5.

Zago, Giulia, Marco Biondini, Jacques Camonis, & Maria Carla Parrini. (2017). A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration. Small GTPases. 10(5). 323–330. 26 indexed citations

6.

Rose, April A. N., Matthew G. Annis, Dennie T. Frederick, et al.. (2016). MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB. Clinical Cancer Research. 22(24). 6088–6098. 40 indexed citations

7.

Biondini, Marco, Perrine Paul‐Gilloteaux, Giulia Zago, et al.. (2016). Direct interaction between exocyst and Wave complexes promotes cell protrusions and motility. Journal of Cell Science. 129(20). 3756–3769. 19 indexed citations

8.

Biondini, Marco & Tiziana Cardinali. (2016). Existence of Solutions for a Nonlinear Integral Equation via a Hybrid Fixed Point Theorem. Results in Mathematics. 71(3-4). 1259–1276. 2 indexed citations

9.

Biondini, Marco, Guillaume Duclos, Nathalie Meyer‐Schaller, et al.. (2015). RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1. Scientific Reports. 5(1). 11759–11759. 32 indexed citations

10.

Déforet, Maxime, Maria Carla Parrini, Laurence Petitjean, et al.. (2012). Automated velocity mapping of migrating cell populations (AVeMap). Nature Methods. 9(11). 1081–1083. 52 indexed citations

11.

Parrini, Maria Carla, Kazuhiro Aoki, Katsuyuki Kunida, et al.. (2011). SH3BP1, an Exocyst-Associated RhoGAP, Inactivates Rac1 at the Front to Drive Cell Motility. Molecular Cell. 42(5). 650–661. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact